Icagen Inc. said it has completed its acquisition of Sanofi's research facility in Oro Valley, near Tucson, enabling Icagen to enhance its expertise as a specialized pharmaceutical services company.
The acquisition includes an agreement between Icagen and Sanofi for a multiyear services contract.
"The acquisition of Sanofi's West Coast ultra high throughput screening biology and chemistry capabilities complements our scientific expertise enabling us to offer a broad range of integrated drug discovery services in a growing market," Icagen President and CEO Richard Cunningham said.
Scientists at the Oro Valley site bring a high level of proficiency in synthetic and computational chemistry and additional capabilities for rare disease biology and phenotypic screening, Douglas Krafte, chief scientific officer at Icagen, said.
4222 Emperor Blvd
Durham, NC - 27703